<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03573271</url>
  </required_header>
  <id_info>
    <org_study_id>AIS 700-00041</org_study_id>
    <nct_id>NCT03573271</nct_id>
  </id_info>
  <brief_title>Pivotal Study to Evaluate the Effectiveness of a Micro-coring Device Treating Moderate to Severe Facial Wrinkles</brief_title>
  <official_title>A Prospective, Multi-center, Pivotal Study to Evaluate the Safety and Efficacy of a Micro-Coring Device for the Treatment of Moderate to Severe Facial Wrinkles</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cytrellis Biosystems, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cytrellis Biosystems, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study evaluating the effectiveness of a micro-coring device for the treatment of moderate to
      severe cheek wrinkles.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Up to 60 subjects who meet the Inclusion/Exclusion criteria will be treated. All subjects
      will be monitored for a period of 90 days after treatments.

      Evaluation results will be based in the following:

        -  Wrinkle severity score assessed using the Lemperle Wrinkle Scale

        -  Subject Satisfaction Scale

        -  PI Global Aesthetic Improvement Scale
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">March 22, 2018</start_date>
  <completion_date type="Anticipated">March 21, 2019</completion_date>
  <primary_completion_date type="Anticipated">January 15, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assess level of wrinkle improvement using the Lemperle Wrinkle Severity Scale at 90 days post treatment</measure>
    <time_frame>90 day post treatment</time_frame>
    <description>Assess level of wrinkle improvement from the baseline to 90 day post treatment an Independent Reviewer(s) using the Lemperle Wrinkle Severity Scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assess safety profile by recording of adverse events</measure>
    <time_frame>90 days</time_frame>
    <description>Adverse events will be recorded throughout the study</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Laxity; Skin</condition>
  <arm_group>
    <arm_group_label>Micro-coring of facial/neck skin with MCD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Micro coring of facial and neck skin will be conducted in up to 2 treatments and followed 90 days post treatment with MCD</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MCD</intervention_name>
    <description>Micro-coring skin removal with automated coring device</description>
    <arm_group_label>Micro-coring of facial/neck skin with MCD</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and females 40-70 years of age

          -  Fitzpatrick Skin Type I to IV as judged by the Investigator.

          -  Cheek areas are at least a score of 3 using the Lemperle Wrinkle Assessment Scale as
             judged by the Investigator

          -  Able to provide written informed consent, understand and willing to comply with all
             study related procedures and follow-up visits

        Exclusion Criteria:

          -  Lesions suspicious for any malignancy or the presence of actinic keratosis, melasma,
             vitiligo, cutaneous papules/nodules or active inflammatory lesions in the areas to be
             treated

          -  History of keloid formation or hypertrophic scarring

          -  History of trauma or surgery to the treatment areas in the past 6 months

          -  Scar present in the areas to be treated

          -  Silicone injections in the areas to be treated

          -  Injection of dermal fillers, fat or botulinum toxin, as well as any minimally
             invasive/invasive medical device for skin treatment, in the study treatment areas,
             within the past 6 months (i.e., dermabrasion, laser, RF devices)

          -  Active smokers (0.5 pack/day) or having quit within 3 months prior to treatment

          -  Active, chronic, or recurrent infection

          -  History of compromised immune system or currently being treated with immunosuppressive
             agents

          -  History of sensitivity to analgesic agents, AquaphorÂ®, topical or local anesthetics
             (e.g., lidocaine, benzocaine, procaine) or chlorhexidine, povidone-iodine or
             epinephrine

          -  Excessive sun exposure and use of tanning beds or tanning creams within 30 days prior
             to treatment

          -  Treatment with aspirin or other blood thinning agents within 14 days prior to
             treatment

          -  History or presence of any clinically significant bleeding disorder

          -  Any issue that, at the discretion of the Investigator, would interfere with assessment
             of safety or efficacy or compromise the subject's ability to participate in the study

          -  Treatment with an investigational device or agent within 30 days before treatment or
             during the study period

          -  Female and pregnant or plan on becoming pregnant during the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Laser and Skin Surgery Center of Northern California</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95816</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Miami Dermatology and Laser Institute</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33173</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole Rieth</last_name>
      <phone>305-279-6060</phone>
      <email>nicoler@miamidermlaser.com</email>
    </contact>
    <investigator>
      <last_name>Jill Waibel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Laser and Skin Surgery Center of New York</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Brittany Schmidt</last_name>
      <phone>212-686-7306</phone>
    </contact>
    <investigator>
      <last_name>Roy Geroneumus, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Practice of Brian S. Biesman, M.D</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dr A Jay Burns Cosmetic Surgery</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75231</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Casey Martin</last_name>
      <phone>603-332-5211</phone>
    </contact>
    <investigator>
      <last_name>A. Jay Burns, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>June 14, 2018</study_first_submitted>
  <study_first_submitted_qc>June 27, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 29, 2018</study_first_posted>
  <last_update_submitted>June 27, 2018</last_update_submitted>
  <last_update_submitted_qc>June 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>facial wrinkles</keyword>
  <keyword>skin laxity</keyword>
  <keyword>sagging skin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cutis Laxa</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

